Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...

Health-care companies fell as traders weighed risks in a wave of deal activity. Pfizer joined Big Pharma rivals hunting for novel weight loss drugs in the Chinese biotech sector.

Jeff Williams, a former Apple executive, will stand for election as a new independent director of Disney at the 2026 annual ...

The executive, who would expand the size of the board to a total of 11 members, will stand election at the media giant's 2026 annual meeting of shareholders ...

The Florida Gators have a new football coach but that coach, Jon Sumrall, is still coaching Tulane, which plays North Texas ...

As Adam Fein of Drug Channels Institute puts it, these forces are finally puncturing the “ gross-to-net bubble ”—the vast gap ...

Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type II ...

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK ...

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

The panel will work with a national firm to hire a successor to Thorr Bjorn, who will depart at the end of November after 18 years in Kingston.

For 2026, the plan features significantly lower out-of-pocket costs for members who use the plan’s “narrow network” that ...

Welcome The Hill’s annual list of Top Lobbyists. President Trump’s return to the White House brought a whirlwind of policy ...